Decrease in hospital admissions for respiratory diseases during the COVID-19 pandemic: a nationwide claims study.
Thorax
; 76(9): 939-941, 2021 09.
Article
in English
| MEDLINE | ID: covidwho-1158124
ABSTRACT
Non-pharmaceutical interventions (NPIs) have been widely implemented to mitigate the spread of COVID-19. We assessed the effect of NPIs on hospitalisations for pneumonia, influenza, COPD and asthma. This retrospective, ecological study compared the weekly incidence of hospitalisation for four respiratory conditions before (January 2016-January 2020) and during (February-July 2020) the implementation of NPI against COVID-19. Hospitalisations for all four respiratory conditions decreased substantially during the intervention period. The cumulative incidence of admissions for COPD and asthma was 58% and 48% of the mean incidence during the 4 preceding years, respectively.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Patient Admission
/
Asthma
/
Pulmonary Disease, Chronic Obstructive
/
Influenza, Human
/
COVID-19
Type of study:
Observational study
Limits:
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
Thorax
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS